Your Cart ( 1 Item )

• Safety Observations in 12095 Patients With Psoriasis Enrolled in an International Registry (PSOLAR): Experience With Infliximab and Other Systemic and Biologic Therapies
  December 2014 | Volume 13 | Issue 12 | Original Article | 1441 | Copyright © December 2014
  Alice B. Gottlieb MD PhD,¹ Robert E. Kalb MD,² Richard G. Langley MD,³ Gerald G. Krueger MD,⁴
  Elke M.G.J. de Jong MD PhD,⁵ Lynn Guenther MD,⁶ Kavitha Goyal MD,⁷ Steven Fakharzadeh MD PhD,⁷
  Marc Chevrier MD PhD,⁷ Stephen Calabro MS,⁷ Wayne Langholff PhD,⁸ Alan Menter MD⁹
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs